rolipram has been researched along with Astrocytoma, Grade IV in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rolipram-treated A172 or U87MG cell survival was lower in the presence of forskolin, adenylate cyclase activator, than that in its absence." | 1.38 | Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways. ( Kim, HM; Lee, GH; Lee, JW; Lee, MS; Moon, EY, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahin, Z | 1 |
| Biltekin, SN | 1 |
| Yurttas, L | 1 |
| Berk, B | 1 |
| Özhan, Y | 1 |
| Sipahi, H | 1 |
| Gao, ZG | 1 |
| Jacobson, KA | 1 |
| Demirayak, Ş | 1 |
| Ou, M | 1 |
| Cho, HY | 1 |
| Fu, J | 1 |
| Thein, TZ | 1 |
| Wang, W | 1 |
| Swenson, SD | 1 |
| Minea, RO | 1 |
| Stathopoulos, A | 1 |
| Schönthal, AH | 1 |
| Hofman, FM | 1 |
| Tang, L | 1 |
| Chen, TC | 1 |
| Ramezani, S | 1 |
| Vousooghi, N | 1 |
| Ramezani Kapourchali, F | 1 |
| Yousefzadeh-Chabok, S | 1 |
| Reihanian, Z | 1 |
| Alizadeh, AM | 1 |
| Khodayari, S | 1 |
| Khodayari, H | 1 |
| Moon, EY | 1 |
| Lee, GH | 1 |
| Lee, MS | 1 |
| Kim, HM | 1 |
| Lee, JW | 1 |
| Yang, L | 1 |
| Jackson, E | 1 |
| Woerner, BM | 1 |
| Perry, A | 1 |
| Piwnica-Worms, D | 1 |
| Rubin, JB | 1 |
5 other studies available for rolipram and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.
Topics: Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclic Nuc | 2021 |
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.
Topics: Autophagy; Cell Death; Chloroquine; Glioblastoma; Glioma; Humans; Lysosomes; Monoterpenes; Rolipram; | 2023 |
Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevaciz | 2019 |
Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Topics: 1-Methyl-3-isobutylxanthine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neopla | 2012 |
Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.
Topics: Animals; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC | 2007 |